ReviewWorld journal of surgical oncology2026
Diagnosis and treatment strategies for autoimmune pancreatitis combined with pancreatic neuroendocrine tumors.
Review in World journal of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune pancreatitis (AIP) and pancreatic neuroendocrine neoplasia (pNET) are two diseases with distinct pathophysiological mechanisms. However, the phenomenon of their coexistence in the same patient is increasingly gaining clinical attention. Although the mechanism behind this co-occurrence is not yet fully understood, the chronic inflammatory microenvironment may play a key role. This review aims to discuss the potential pathogenetic links between AIP and pNET coexistence, focusing on analysing the unique challenges and corresponding strategies in imaging diagnosis. Furthermore, the multidisciplinary team (MDT) collaborative model was used to construct a personalized treatment framework guided primarily by pNET risk stratification while also considering AIP disease activity. A deep understanding of this coexistence is crucial for clinicians to achieve accurate diagnoses, optimize treatment decisions, and improve patient prognosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.